During the 2019 IPPE show, Phibro Animal Health will introduce its new Provia™ Prime direct fed microbial product that helps optimize the gut microbiome for improved health, immunity and productivity in poultry. “A healthy microbiome can […]
Scientists working on the gut microbiome* have discovered and isolated more than 100 completely new species of bacteria from healthy people’s intestines. The study from the Wellcome Sanger Institute, Hudson Institute of Medical Research, Australia, […]
Pivot Bio announced that its flagship product, Pivot Bio PROVEN™, outperformed chemical nitrogen fertilizer in the company’s 2018 national trials. Growers using Pivot Bio PROVEN™, the industry’s first sustainable nitrogen-producing microbe for corn, consistently observed […]
Viome announces it has entered into an agreement with Campbell Soup Company (NYSE:CPB) to acquire Habit, a leading personalized nutrition company that takes the guesswork out of eating right. Now operating as one, the two […]
While“healthy” microbiome remains to be defined, microbiome disruption is associated with numerous diseases, offering new therapeutic opportunities if causalities are demonstrated. Europe is at the forefront of the understanding of the Microbiome and is well placed […]
The list of presentations from any recent microbiome conference shows the diversity of approaches by which scientists are pursuing discovery of microbiome-focused therapeutics. And common to all of these approaches is the essential need to […]
The Pharmabiotic Research Institute (PRI), a non-for-profit pro industry group that assists its members with the development of their Microbiotic Medicinal Products (MMPs) is hosting an ‘/OMICS’ Task Group March 14th in Paris, following Pharmabiotics 2019 Conference […]
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a Japanese dairy product company, today announced new research showing that consumption of its proprietary probiotic Morinaga Bifidobacterium infantis M-63 improved the mental state of victims of the disastrous 2014-2015 […]
4D pharma plc (AIM: DDDD) announces the publication of a paper outlining the mechanism and strong immuno-stimulatory effects of MRx0518. The paper ‘The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant‘ […]
Archer Daniels Midland Company (NYSE: ADM) announced today that it has successfully completed its €1.544 billion acquisition of Neovia, creating a global leader in value-added products and solutions for both production and companion animals. “The […]
Azitra, Inc., a company developing microbiome-based cosmetics and therapeutics to treat skin diseases and conditions, announced that enrollment has been completed for the first human safety study of AZT-04. AZT-04 is the Company’s lead product […]